-
NUMBER OF INSIDER BUYING
(Last 12 Months)
2 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
0 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$6.11 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$0
Neumora Therapeutics, Inc. Common Stock Insider Transactions
Neumora Therapeutics, Inc. Common Stock Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Burow Kristina
Director, 10 percent owner: |
Buy | 34,560 @ $13.98 | $483,149 | 3,859,898 | 09/29/2023 | 09/29/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 34,560 @ $13.98 | $483,149 | 3,859,898 | 09/29/2023 | 09/29/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 25,110 @ $13.69 | $343,756 | 3,825,338 | 09/28/2023 | 09/29/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 16,841 @ $13.06 | $219,943 | 3,800,228 | 09/28/2023 | 09/29/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 25,110 @ $13.69 | $343,756 | 3,825,338 | 09/28/2023 | 09/29/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 16,841 @ $13.06 | $219,943 | 3,800,228 | 09/28/2023 | 09/29/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 24,504 @ $12.31 | $301,644 | 3,783,387 | 09/27/2023 | 09/27/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 24,504 @ $12.31 | $301,644 | 3,783,387 | 09/27/2023 | 09/27/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 34,000 @ $11.73 | $398,820 | 3,758,883 | 09/26/2023 | 09/27/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 34,000 @ $11.73 | $398,820 | 3,758,883 | 09/26/2023 | 09/27/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 29,967 @ $11.65 | $349,116 | 3,724,883 | 09/25/2023 | 09/25/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 30,773 @ $10.80 | $332,348 | 3,694,916 | 09/25/2023 | 09/25/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 29,967 @ $11.65 | $349,116 | 3,724,883 | 09/25/2023 | 09/25/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 30,773 @ $10.80 | $332,348 | 3,694,916 | 09/25/2023 | 09/25/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 40,000 @ $11.14 | $445,600 | 3,664,143 | 09/22/2023 | 09/25/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 40,000 @ $11.14 | $445,600 | 3,664,143 | 09/22/2023 | 09/25/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 1,500,000 @ $17.00 | $25.50 M | 3,624,143 | 09/19/2023 | 09/20/2023 | |
ARCH Venture Partners X, LLC
10 percent owner |
Buy | 1,500,000 @ $17.00 | $25.50 M | 3,624,143 | 09/19/2023 | 09/20/2023 | |
Buy | 15,000 @ $12.62 | $189,371 | 15,000 | 09/19/2023 | 09/19/2023 |
Neumora Therapeutics, Inc. Common Stock Frequently Asked Questions
-
Who is on Neumora Therapeutics, Inc. Common Stock's Insider Roster?
The list of insiders at Neumora Therapeutics, Inc. Common Stock includes ARCH Venture Partners XII, LLC, Burow Kristina.
-
How much insider buying is happening at Neumora Therapeutics, Inc. Common Stock?
Insiders have purchased a total of 542,618 Neumora Therapeutics, Inc. Common Stock shares in the last 12 months for a total of 6.11 M sold.
-
Which Neumora Therapeutics, Inc. Common Stock insiders have been buying company stock?
The following insiders have purchased Neumora Therapeutics, Inc. Common Stock shares in the last 12 months: ARCH Venture Partners XII, LLC ($3.06 M), Burow Kristina ($3.06 M),